Evonik can initiate the development of long-acting, injectable microparticle and implant products through feasibility assessments and proof-of-concept studies. With extensive experience supporting all classes of drugs, both new chemical entities (NCEs) and approved drug substances, Evonik provides the formulation, excipient, and process expertise needed to evaluate formulation approaches, mitigate development risks, and accelerate progress toward successful long-acting drug delivery solutions.
Benefits at a glance
- Experience: Evonik's formulation experience and drug delivery technologies come from providing formulation services and innovation for 50+ years.
- Versatile: Enables both implants and microparticles dosage forms
- Route: Multiple administration routes
- Safe: Uses biocompatible, bioabsorbable RESOMER® and LACTEL® polymers.
- Trusted: Lactide/glycolide polymers are used in 60+ approved products.